97 related articles for article (PubMed ID: 1591945)
1. An alkaloid, cepharanthine, potentiates the bactericidal effect of methylglyoxal bis (cyclopentylamidinohydrazone) on Staphylococcus aureus.
Hibasami H; Midorikawa Y; Takaji S; Nakashima K
Chemotherapy; 1992; 38(2):107-11. PubMed ID: 1591945
[TBL] [Abstract][Full Text] [Related]
2. Cepharanthine potentiates the antitumor effect of methylglyoxal bis (cyclopentylamidinohydrazone) on human leukemia cells.
Hibasami H; Takaji S; Murata T; Nakashima K
Anticancer Res; 1991; 11(4):1543-7. PubMed ID: 1746912
[TBL] [Abstract][Full Text] [Related]
3. Dioxopiperazine derivative potentiates antitumor effect of methylglyoxal bis(cyclopentylamidinohydrazone) on human and mouse leukemia cells.
Hibasami H; Tsukada T; Shirakawa S; Narita T; Inagaki M; Nakashima K
Anticancer Res; 1994; 14(2A):561-4. PubMed ID: 8017861
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylglyoxal bis (cyclopentylamidinohydrazone) (MGBCP) on cell cycle progression in three human osteosarcoma cell lines.
Mori K; Hibasami H; Sonoda J; Fujinami S; Sekiguchi S; Tajima M; Yamazaki T; Higuchi S; Uchida A; Nakashima K
Anticancer Res; 1996; 16(5A):2565-7. PubMed ID: 8917352
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction in human breast cancer MRK-nu-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone)(MGBCP).
Kaneko H; Hibasami H; Mori K; Kawarada Y; Nakashima K
Anticancer Res; 1998; 18(2A):891-6. PubMed ID: 9615737
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptotic cell death in three human osteosarcoma cell lines by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP).
Mori K; Hibasami H; Satoh N; Sonoda J; Yamasaki T; Tajima M; Higuchi S; Wakabayashi H; Kaneko H; Uchida A; Nakashima K
Anticancer Res; 1997; 17(4A):2385-9. PubMed ID: 9252651
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of a new multienzyme inhibitor of polyamine synthetic pathway, methylglyoxal-bis(cyclopentylamidinohydrazone), against human and mouse leukemia cells.
Hibasami H; Maekawa S; Murata T; Nakashima K
Cancer Res; 1989 Apr; 49(8):2065-8. PubMed ID: 2702649
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antimicrobial activity of methylglyoxal bis(guanylhydrazone) analogues, the inhibitors for polyamine biosynthetic pathway.
Midorikawa Y; Hibasami H; Gasaluck P; Yoshimura H; Masuji A; Nakashima K; Imai M
J Appl Bacteriol; 1991 Apr; 70(4):291-3. PubMed ID: 2055790
[TBL] [Abstract][Full Text] [Related]
9. Methylglyoxal bis (cyclopentylamidinohydrazone) (MGBCP): antitumor effect against human osteosarcoma cells and combined effect with methotrexate, adriamycin and 4-hydroperoxyifosfamide.
Sonoda J; Hibasami H; Yamada H; Fujinami S; Nakashima K; Ogihara Y
Anticancer Res; 1995; 15(3):907-9. PubMed ID: 7645980
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of Helicobacter pylori by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone).
Takaji S; Hibasami H; Imoto I; Hashimoto Y; Nakao K; Ikemura N; Taguchi Y; Nakashima K
Lett Appl Microbiol; 1997 Sep; 25(3):177-80. PubMed ID: 9351259
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptotic cell death in human hepatocellular carcinoma SK-HEP-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone).
Hashimoto Y; Hibasami H; Tamaki S; Kamei A; Ikoma J; Kaito M; Imoto I; Watanabe S; Nakashima K; Adachi Y
Anticancer Drugs; 1999 Mar; 10(3):323-7. PubMed ID: 10327040
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human osteosarcoma HuO9 cells by methylglyoxal bis(cyclopentylamidinohydrazone) in vitro and in vivo.
Satoh N; Hibasami H; Mori K; Kaneko H; Wakabayashi H; Hirata K; Sonoda J; Nakashima K; Uchida A
Oncol Rep; 1999; 6(3):627-30. PubMed ID: 10203604
[TBL] [Abstract][Full Text] [Related]
13. Involvement of apoptosis and cyclin D1 gene repression in growth inhibition of T-47D human breast cancer cells by methylglyoxal bis(cyclopentylamidinohydrazone).
Kaneko H; Hibasami H; Satoh N; Wakabayashi H; Ikeda H; Tsuge N; Yonemaru K; Muraki A; Kawarada Y; Nakashima K
Int J Mol Med; 1998 Jun; 1(6):931-6. PubMed ID: 9852627
[TBL] [Abstract][Full Text] [Related]
14. Prevention of metastasis by a polyamine synthesis inhibitor in an animal bone metastasis model.
Wakabayashi H; Hibasami H; Iida K; Satoh N; Yamazaki T; Sonoda J; Hirata H; Nakashima K; Uchida A
Oncology; 2000 Jun; 59(1):75-80. PubMed ID: 10895071
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
Kato T; Suzumura Y
J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
[TBL] [Abstract][Full Text] [Related]
16. Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
Shiraishi N; Shimada T; Hagino Y; Kohno K; Kobayashi M; Kuwano M; Akiyama S
Cancer Res; 1988 Mar; 48(5):1307-11. PubMed ID: 3257717
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells.
Sakaguchi S; Furusawa S; Wu J; Nagata K
Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386
[TBL] [Abstract][Full Text] [Related]
18. Effects of biscoclaurine alkaloid cepharanthine on newborn rat skin epidermal and dermal cells.
Ohkura K; Urakami K; Makino S; Terada H
Biol Pharm Bull; 1996 Apr; 19(4):495-500. PubMed ID: 8860946
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids].
Kubota R; Kubota K; Yamada S
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2163-7. PubMed ID: 1444481
[TBL] [Abstract][Full Text] [Related]
20. Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitro.
Nagaoka S; Kawasaki S; Karino Y; Sasaki K; Nakanishi T
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1297-302. PubMed ID: 3678324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
